Brightpoint, Inc. (CELL) Misses Q2 EPS by 2c

Brightpoint, Inc. (NASDAQ: CELL) reported Q2 EPS of $0.13, $0.02 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.34 billion.

For earnings history and earnings-related data on Brightpoint, Inc. (CELL) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Pan American Silver (PAAS) Misses Q2 EPS by 19c
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance